We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+7.33%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.44B
AUM Growth
+$259M
(+4.2%)
Cap. Flow
+$405M
Cap. Flow
% of AUM
6.29%
Top 10 Holdings %
Top 10 Hldgs %
34.31%
Holding
1,318
New
461
Increased
339
Reduced
236
Closed
232
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$330M |
| 2 |
Brookdale Senior Living
BKD
|
+$93.7M |
| 3 |
Tenet Healthcare
THC
|
+$85.2M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$70.6M |
| 5 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$64.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$206M |
| 2 |
CVS Health
CVS
|
+$122M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$102M |
| 4 |
McKesson
MCK
|
+$80.6M |
| 5 |
Pacira BioSciences
PCRX
|
+$45.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.63% |
| 2 | Energy | 5.88% |
| 3 | Consumer Discretionary | 5.63% |
| 4 | Financials | 4.88% |
| 5 | Industrials | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GGP
951
DELISTED
GGP Inc.
GGP
| $220K | ﹤0.01% |
+9,343
| New | +$217K |
|
952
Valley National Bancorp
VLY
$7.9B
| $219K | ﹤0.01% |
+22,086
| New | +$222K |
|
953
UGI
UGI
$7.87B
| $218K | ﹤0.01% |
+6,464
| New | +$204K |
|
954
Travel + Leisure Co
TNL
$4.76B
| $216K | ﹤0.01% |
+6,324
| New | +$208K |
|
|
PETM
955
DELISTED
PETSMART INC
PETM
| $216K | ﹤0.01% |
+3,619
| New | +$228K |
|
956
Vipshop
VIPS
$7.26B
| $215K | ﹤0.01% |
11,470
-5,740
| -33% | -$92K |
|
|
AHL
957
PUT
DELISTED
ASPEN Insurance Holding Limited
AHL
| $215K | ﹤0.01% |
+92,500
| New | +$4.14M |
|
958
Cadence Design Systems
CDNS
$91.8B
| $213K | ﹤0.01% |
12,191
-33,109
| -73% | -$529K |
|
959
Diamondback Energy
FANG
$56B
| $212K | ﹤0.01% |
+2,388
| New | +$182K |
|
960
Cheesecake Factory
CAKE
$5.03B
| $211K | ﹤0.01% |
+4,543
| New | +$209K |
|
961
Charter Communications
CHTR
$17.3B
| $209K | ﹤0.01% |
+1,320
| New | +$182K |
|
962
United Airlines
UAL
$38.8B
| $208K | ﹤0.01% |
+5,065
| New | +$218K |
|
|
ETFC
963
DELISTED
E*Trade Financial Corporation
ETFC
| $207K | ﹤0.01% |
9,728
-18,264
| -65% | -$384K |
|
964
Viatris
VTRS
$20.8B
| $206K | ﹤0.01% |
4,000
-174
| -4% | -$8.55K |
|
|
CPN
965
DELISTED
Calpine Corporation
CPN
| $206K | ﹤0.01% |
8,658
-1,068
| -11% | -$24.2K |
|
|
MHR
966
DELISTED
MAGNUM HUNTER RESOURCES CORP (DEL)
MHR
| $206K | ﹤0.01% |
+25,130
| New | +$205K |
|
967
Thor Industries
THO
$4.06B
| $205K | ﹤0.01% |
+3,606
| New | +$216K |
|
|
WEB
968
DELISTED
Web.com Group, Inc.
WEB
| $205K | ﹤0.01% |
+7,104
| New | +$233K |
|
969
Nordson
NDSN
$16.4B
| $204K | ﹤0.01% |
2,550
-34,042
| -93% | -$2.62M |
|
970
Charles River Laboratories
CRL
$11.3B
| $203K | ﹤0.01% |
3,800
-25,900
| -87% | -$1.42M |
|
|
ISBC
971
DELISTED
Investors Bancorp, Inc.
ISBC
| $203K | ﹤0.01% |
+18,346
| New | +$196K |
|
972
Lennox International
LII
$15B
| $201K | ﹤0.01% |
2,243
-15,504
| -87% | -$1.35M |
|
|
UN
973
DELISTED
Unilever NV New York Registry Shares
UN
| $201K | ﹤0.01% |
+4,600
| New | +$197K |
|
|
MXWL
974
DELISTED
Maxwell Technologies Inc
MXWL
| $196K | ﹤0.01% |
+12,961
| New | +$204K |
|
|
CMO
975
DELISTED
Capstead Mortgage Corp.
CMO
| $195K | ﹤0.01% |
+14,846
| New | +$193K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2014 Portfolio in Review
As of Q2 2014, Visium Asset Management held 1,318 positions worth $6.44B, up 4.2% from $6.18B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Visium Asset Management deployed $405M of net new capital in Q2 2014, opening 461 new positions and adding to 339 existing holdings. Its largest new stake was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
By sector, the portfolio is most concentrated in Healthcare at 50% of assets, down from 53% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Bausch Health, an estimated $206M trimmed.
- Visium Asset Management's largest Q2 2014 buy was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
- Visium Asset Management added most to Allergan Inc in Q2 2014, an estimated $330M increase.
- Visium Asset Management's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $206M.
- Visium Asset Management fully exited QUESTCOR PHARMA INC in Q2 2014, selling an estimated $34M.
- Visium Asset Management's ten largest holdings make up 34% of its $6.44B portfolio in Q2 2014.
- Visium Asset Management opened 461 new positions and closed 232 in Q2 2014.
- Visium Asset Management's portfolio value rose 4.2% quarter-over-quarter to $6.44B.
Based on Visium Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.